DexCom is reported to be in talks with Insulet to acquiring the insulin pump manufacturer, as reported by Bloomberg on 23 May.
The deal, which would combine Dexcom’s $31.8bn market cap with Insulet’s $14
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?